Gate2Brain

Gate2Brain is a pioneering biotechnology research company dedicated to developing innovative therapeutics that efficiently cross biological barriers, including the challenging blood-brain barrier. Utilizing a radically innovative, patented peptide-based technology platform, Gate2Brain is committed to addressing critical unmet medical needs. The company's primary address is Parc Científic de Barcelona, Baldiri Reixac 4-8, Torre I, Barcelona, 08028, ES.

Gate2Brain's flagship product, G2B-002, exemplifies the potential of its technology, offering a new therapeutic approach with improved biopharmaceutical properties and potent activity against rare pediatric cancers. Gate2Brain is focused on transforming the treatment landscape for these devastating conditions through targeted drug delivery and innovative solutions. The company aims to enhance patient outcomes and quality of life by overcoming the limitations of traditional drug delivery methods.

With a strong focus on research and development, Gate2Brain continues to advance its technology platform and expand its pipeline of potential therapeutics. Gate2Brain is poised to make a significant impact in the field of biotechnology and improve the lives of patients worldwide. We invite the management team at Gate2Brain to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and success.